Top 50 Medical Device Startup Investors in United States (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Innova Memphis
VC Fund
|
72 | United States, Argentina, United Kingdom | Seed, Pre-Seed, Convertible Note | Health Care, Medical, Medical Device | $50k–$1.7M |
|
TEDCO
VC Fund
|
28 | United States, Canada, Colombia | Seed, Grant, Pre-Seed | Health Care, Software, Biotechnology | $25k–$2.5M |
|
Gaingels
VC Fund
|
23 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1M–$100M |
|
Right Side Capital Management
VC Fund
|
23 | United States, Canada, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, SaaS, Health Care | $20k–$2M |
|
Portfolia
VC Fund
|
22 | United States, Canada, Germany | Seed, Series A, Series B | Health Care, Biotechnology, Software | $125k–$59M |
|
Alumni Ventures
VC Fund
|
22 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$79M |
|
SOSV
VC Fund
|
20 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
HealthTech Capital
VC Fund
|
20 | United States, Canada | Seed, Series A, Convertible Note | Health Care, Medical Device, Medical | $1M–$16M |
|
CincyTech
VC Fund
|
18 | United States | Seed, Series A, Series B | Software, Health Care, Information Technology | $250k–$30M |
|
Broadview Ventures
VC Fund
|
17 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
New York Angels
VC Fund
|
17 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, Health Care, Mobile | $517k–$15M |
|
Khosla Ventures
VC Fund
|
16 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Health Care | $2M–$100M |
|
Texas HALO Fund
VC Fund
|
16 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
Arboretum Ventures
VC Fund
|
16 | United States, Canada, Israel | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $4.4M–$80M |
|
North Coast Ventures
VC Fund
|
16 | United States | Series A, Seed | Health Care, Software, Medical Device | $350k–$14M |
|
Sand Hill Angels
VC Fund
|
16 | United States, Canada, El Salvador | Seed, Series A, Series B | Health Care, Software, Biotechnology | $1M–$130M |
|
Wavemaker 360
VC Fund
|
16 | United States, United Kingdom, Canada | Seed, Series A, Series B | Health Care, Medical, Artificial Intelligence | $750k–$30M |
|
Connecticut Innovations
VC Fund
|
16 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $300k–$25M |
|
MB Venture Partners
VC Fund
|
15 | United States, Israel | Seed, Series B, Series C | Health Care, Medical, Medical Device | $50k–$28M |
|
TCA Venture Group
VC Fund
|
15 | United States, Canada | Seed, Convertible Note | Health Care, Software, Biotechnology | $100k–$7M |
|
Maine Angels
VC Fund
|
15 | United States | Seed, Series A | Health Care, Software, Biotechnology | $25k–$5.9M |
|
Oxford Finance LLC
VC Fund
|
15 | United States, United Kingdom, Canada | Debt Financing, Post-IPO Debt, Series B | Biotechnology, Health Care, Medical | $7.5M–$150M |
|
Keiretsu Capital
VC Fund
|
15 | United States, Canada, India | Series A, Seed | Health Care, Biotechnology, Medical | $700k–$12M |
|
Launch NY
VC Fund
|
15 | United States, Canada, Denmark | Convertible Note, Seed, Pre-Seed | Software, Health Care, Food and Beverage | $13k–$2.2M |
|
Golden Seeds
VC Fund
|
14 | United States, Canada | Series A, Seed, Series B | Health Care, Software, Biotechnology | $740k–$20M |
|
Horizon Technology Finance
VC Fund
|
14 | United States, Canada, India | Debt Financing, Post-IPO Debt, Series C | Health Care, Biotechnology, Medical Device | $2.8M–$200M |
|
Boston Harbor Angels
VC Fund
|
14 | United States, Canada, India | Angel, Seed, Series A | Health Care, Biotechnology, Medical Device | $100k–$6M |
|
Life Science Angels
VC Fund
|
14 | United States, Israel, The Netherlands | Seed, Series A | Biotechnology, Health Care, Medical | $1M–$20M |
|
Good Growth Capital
VC Fund
|
14 | United States, France, Israel | Seed, Series A, Convertible Note | Health Care, Biotechnology, Software | $25k–$20M |
|
Ben Franklin Technology Partners of Southeastern Pennsylvania
VC Fund
|
13 | United States | Seed, Grant, Debt Financing | Health Care, Software, Information Technology | $5k–$2.2M |
|
Versant Ventures
VC Fund
|
13 | United States, Switzerland, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $5M–$108M |
|
Catalyst Health Ventures
VC Fund
|
13 | United States | Series B, Series A, Series C | Health Care, Medical Device, Biotechnology | $1.3M–$85M |
|
Hatteras Venture Partners
VC Fund
|
12 | United States, Canada | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $5M–$90M |
|
Everywhere Ventures
VC Fund
|
12 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $500k–$20M |
|
Wisconsin Investment Partners
VC Fund
|
12 | United States, Canada, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical | $400k–$7M |
|
Boutique Venture Partners
VC Fund
|
12 | United States, Canada, France | Seed, Series A, Pre-Seed | Health Care, Medical, Biotechnology | $1.8M–$31M |
|
SBXi
VC Fund
|
12 | United States, India, Mexico | Pre-Seed, Seed, Venture - Series Unknown | Artificial Intelligence, Software, Information Technology | $100k–$7M |
|
Rev1 Ventures
VC Fund
|
12 | United States, Germany | Seed, Series A | Software, Health Care, Information Technology | $192k–$18M |
|
Mayo Clinic
VC Fund
|
12 | United States, Canada, Israel | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $100k–$100M |
|
U.S. Venture Partners
VC Fund
|
12 | United States, Israel, Canada | Series B, Series C, Series A | Software, Health Care, Information Technology | $5M–$68M |
|
Keiretsu Forum
VC Fund
|
12 | United States, India, Turkey | Seed, Series A | Health Care, Software, Biotechnology | $85k–$10M |
|
St. Louis Arch Angels
VC Fund
|
12 | United States, Argentina | Seed, Series A | Biotechnology, Health Care, Medical Device | $100k–$8.5M |
|
Kleiner Perkins
VC Fund
|
11 | United States, China, United Kingdom | Series B, Series A, Series C | Software, Health Care, Information Technology | |
|
Shangbay Capital
VC Fund
|
11 | United States, China, Canada | Series A, Series B | Health Care, Medical Device, Medical | $5.1M–$123M |
|
Houston Angel Network
VC Fund
|
11 | United States, Canada, France | Seed, Series A | Health Care, Software, Medical | $25k–$5M |
|
Green Park & Golf Ventures
VC Fund
|
11 | United States, Israel, Sweden | Series A, Seed, Series B | Health Care, Medical, Biotechnology | $420k–$45M |
|
Third Rock Ventures
VC Fund
|
11 | United States | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $11M–$190M |
|
Asset Management Ventures (AMV)
VC Fund
|
11 | United States, Cyprus, Ireland | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $500k–$35M |
|
Robin Hood Ventures
VC Fund
|
11 | United States, Canada, Israel | Seed, Series A | Software, Health Care, Biotechnology | $100k–$11M |
|
The Vertical Group
VC Fund
|
10 | United States, Israel | Series B, Series C | Health Care, Medical Device, Medical | $1.5M–$77M |
| Access all 5158 investors in United States Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Argentina, United Kingdom
Investor stats
- Total investments: 257
- Round size: Seed $50k–$1.7M; Pre-Seed $50k–$1.3M; Convertible Note $250k–$1.4M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- HerdDogg — HerdDogg is a global herd health and data science platform. It is a two-part system that helps ranchers track health and proximity data from their herd. The company's device gathers the data captured by the ear tags and reports it directly to the rancher via an app or web database.
- Insignum AgTech — Insignum AgTech develops biotech plants that communicate with producers, alerting them to an illness in its early stages.
- Rescue Forensics — Customer service is our #1 priority. Get a premium domain for your website today. Financing available.
TEDCO is an independent organization that strives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Grant, Pre-Seed
- Geography: United States, Canada, Colombia
Investor stats
- Total investments: 334
- Round size: Seed $100k–$2.5M; Grant $54k–$1M; Pre-Seed $25k–$900k
- Lead/follow: 70% lead, 30% follow
Portfolio highlights
- AGED Diagnostics — AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis (NASH, liver disease) and fibrosis (liver scarring). AGED tools can simultaneously stage fibrosis and distinguish benign from severe liver disease (liver scarring). This method measures the concentration of target biomarkers (genetic signatures) in circulation using atargeted genomic sequencing assessment. When biomarkers are detected over a specific quantity, liver disease (NASH) and/or fibrosis are diagnosed.
- Makerspace of Annapolis — Makerspace of Annapolis offers access to facilities, equipment & knowledge in the fields of robotics, manufacturing, and computer science.
- Morgan State University — Morgan State University - Maryland's Preeminent Urban Public Research University
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 1258
- Round size: Seed $1M–$8.5M; Series A $5.5M–$37M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Quadient Accounts Receivable by YayPay — YayPay accounts receivable automation software helps businesses collect faster, forecast cash flow accurately, and improve payment process. Automate your AR
- Sharper Sense — Neuromodulation for Clear Senses
- Willow Wealth — Willow Wealth is an alternative investment platform focused on generating income streams for investors. Get exclusive access to private market investments.
Systematic Pre-Seed Startup Capital
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 1452
- Round size: Seed $20k–$2M; Pre-Seed $50k–$450k; Convertible Note $50k–$630k
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- tbh — tbh is a developer of a mobile application designed to provide anonymous feedback to friends. The company's mobile application facilitates asking or answering questions, open text fields and invite abuse when combined with anonymity, enabling users to say things without repercussions and feel better about themselves from the positive feedbackon social networks.
- Cohley — Cohley is a content marketing platform focusing on user generated content, visual asset creation, and text review generation. Streamline your content generation today!
- Vidrovr — Vidrovr develops multimodal computer vision and machine learning systems to index, tag, and understand video. It processes videos with specific domain constraints, such as in sports, government, and media verticals. Its technology enables its users to search an indexed video corpus and retrieve content inside videos and link it to other media likephotos and text.The company Integrates social media to enable direct interactions between multimedia content. Vidrovr was founded in 2016 and is headquartered in New York.
Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 257
- Round size: Seed $1.2M–$5.3M; Series A $125k–$15M; Series B $9M–$59M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $722k in 2022
Portfolio highlights
- AEENA Dx — A brilliant shift in disease detection is coming soon. Learn more A brilliant shift in disease detection is coming soon. Learn more
- Osteoboost — Bone Health Technologies specializes in developing medical devices designed for low bone mass. Its solution is a gentle mechanical stimulation that mimics weight-bearing exercise, providing an effective non-drug intervention. It offers the OsteoBoost device that relies on safe, natural, and effective whole-body vibration technology usingvibrational energy to turn stem cells into the bone using the same mechanisms as physical exercise. The company was founded in 2018 and is headquartered in San Francisco, California.
- Sandstone Diagnostics — Sandstone's Torq technology enables point-of-care clinical diagnostics and care by bringing the sample prep to the patient.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 2214
- Round size: Seed $1.5M–$10M; Series A $5.5M–$35M; Series B $12M–$79M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- WINN.AI — WINN.AI helps revenue teams run better sales calls and win more deals by automating admin work and guiding reps live, during the call.
- Car Body Lab — The easy way, online.
- Perennial — Cloud Agronomics is the platform for soil carbon management.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 98
- Round size: Seed $1M–$3.4M; Series A $1.7M–$16M; Convertible Note $1.3M–$2.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- S2 Genomics — S2 Genomics is developing spatial sequencing technology solutions for processing solid tissues for single-cell applications. It enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies. The company's vision is to provide products that process raw tissues into samples ready for genomicanalyses.S2 Genomics was founded in 2016 and is headquartered in Livermore, CA.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States
Investor stats
- Total investments: 122
- Round size: Seed $250k–$3.9M; Series A $300k–$30M; Series B $2.5M–$11M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $12M in 2023
Portfolio highlights
- Invirsa — Invirsa is developing a unique, broad platform based on a naturally occurring small molecule (INV-102) that has demonstrated enhanced immune response to infection. INV-102 not only reduces viral infection, and potentially bacterial replication, it also reduces inflammation, while enhancing the bodies wound healing response. Invirsa'stechnology is first being developed in the ophthalmology and pulmonary space.Invirsa’s technology has the potential to be a first line therapy for common infectious diseases, whether it's the 100 million viral pulmonary infections or the 5 million infectious conjunctivitis cases that occur every year in the US alone.
- TeamCentral — TeamCentral is a company focused on optimizing productivity through improvements in how data is managed and governed across business systems.
- Ravee Optics — Ravee Optics is a startup company developing ultracompact optical intersatellite links and hardware technology for high data rate communications and data transfer for small satellites and cubesats
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 82
- Round size: Seed $1M–$18M; Series A $1M–$30M; Series B $7M–$45M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!New York Angels is one of the oldest, most prominent angel investment groups in the country. New York Angels has offered early-stage entrepreneurs funding, mentoring, connections and more for over 20 years. Angel investors join New York Angels for their extensive, experienced network, increased de
Show more...Investment focus
- Industry: Software, Health Care, Mobile
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 295
- Round size: Seed $517k–$5M; Series A $1.1M–$9.2M; Series B $2M–$15M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $1.2M in 2012
Portfolio highlights
- Enertiv — Enertiv's is a CRE technology company that transforms building data into asset value. Top owners and operators have adopted Enertiv as their primary smart building technology and a key component in their overall PropTech strategy.
- Linebird — Linebird is revolutionizing electric transmission line maintenance by applying drone technology to a dangerous and labor intensive process.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
Khosla Ventures is a venture capital firm that invests in early- to late-stage companies across sectors like AI, healthcare, sustainability, and consumer technology. It manages multiple funds, focusing on startups with innovative technologies or business models. The firm primarily targets sectors like AI, climate tech, digital health, and medtech,offering strategic support to help build long-lasting companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1253
- Round size: Seed $2M–$27M; Series A $5.7M–$47M; Series B $10M–$100M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $557M in 2022
Portfolio highlights
- Vectra AI — Vectra AI, the cybersecurity AI company that protects modern networks from modern attacks.
- Zebra Medical Vision — NANOX AI enables more accurate risk-adjustment so patients are provided with preventative care paths they need, while improving quality of health services at significantly lower associated costs.
- Blue River Technology — Blue River Technology is a pioneer in the use of computer vision and robotics for agriculture. Founded in 2011 by two Stanford University Alumni, Blue River Technology is bringing crop protection into the digital era with See & Spray machines that precisely observe and treat each plant in a field. By applying herbicides only to weeds thesemachines dramatically reduce the amount of chemicals used, enable farmers the freedom to choose any herbicide that meets their needs, and improve grower economics. Currently, farmers are limited to equipment that applies fertilizer and chemicals inefficiently across an entire field. In contrast, Blue River have developed tractor-towed robots that are able to sense each individual plant and precisely apply the right amount of inputs – all in real time, at tractor speeds.
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 95
- Round size: Seed $105k–$3M; Series A $3M–$10M; Convertible Note $2.5M–$2.6M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $175k in 2021
Portfolio highlights
- Flourish Care — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon-fiber-reinforced plastic recycling process. Vartega develops alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass-market applications.Vartega's patented carbon fiber recycling process scales rapidly to fill a gap in thecomposites supply chain. The company’s carbon fiber is available in semi-continuous, chopped, and milled forms. It is ideally suited for use in thermoplastics, non-wovens, and molding compounds.
For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 116
- Round size: Series A $4.4M–$27M; Series B $5M–$55M; Series C $10M–$80M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — raised $250M in 2019
Portfolio highlights
- Endogenex — DyaMX is an early stage medical device company focused on the treatment of Type 2 Diabetes
- Boomerang Medical — Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
- Pharaoh Neuro — Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Series A, Seed
- Geography: United States
Investor stats
- Total investments: 101
- Round size: Seed $350k–$5.5M; Series A $1.2M–$14M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- FinOpsly — Maximize your cloud ROI with FinOpsly. Our AI-driven platform empowers organizations with smart cost management, fostering collaboration across teams for over 32% in savings. Simplify your cloud strategy with FinOpsly.
- InnerActiv — InnerActiv is the leading NextGen eDLP solution, setting new standards in DLP, fraud and insider threat detection.
- Healia Health — Healia is a company that provides revolutionizing health insurance for dual-income households, saving employers 85% each registered family.
For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, El Salvador
Investor stats
- Total investments: 365
- Round size: Seed $1M–$6.5M; Series A $1.6M–$24M; Series B $8.9M–$130M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Madison Reed — Madison Reed is transforming at home hair color with ammonia free hair dye that results in multi-dimensional color that looks beautiful, healthy and natural.
- Clean Power Finance — Clean Power Finance (CPF) is building an online business-to-business marketplace to drive the mass-market adoption of solar. The company connects providers of capital who are committed to investing in residential solar with qualified solar marketers, installers and distributors who need residential solar finance products to differentiate and growtheir businesses. CPF raises 100 percent third-party‐owned project finance funds from institutional investors such as Morgan Stanley and Google, working with the investors to structure and launch the funds with managed risk and return profiles. CPF then markets the funds as solar leases and power purchase agreements (PPAs) to qualified solar professionals, including Paramount Solar and Real Goods Solar (Nasdaq: RSOL), through its licensed online solar sales platform, CPF Tools. CPF Tools is software-as-a-service that simplifies complex sales, quoting, proposal and finance processes and minimizes the “soft costs” of selling solar.CPF’s fund investors earn favorable returns on stable investments on the resulting portfolios of residential distributed generation projects. The company’s solar professional partners gain access to solar leases and power purchase agreements (PPAs) that they can brand and sell to homeowners who want the benefits of solar without the cost and hassle of owning and maintaining a system.CPF manages approximately half a billion dollars of capacity on behalf of fund investors, and supports more than 100 solar professional customers who currently use the CPF Market to sell residential solar finance products to homeowners in CA, CO, HI, MA and NJ. Thousands of solar professionals in all 50 states have extensively used CPF Tools to quote and design solar systems.
- Front Range Biosciences — Front Range Biosciences brings modern agriculture to cannabis and hemp to improve reliability, efficiency, and safety for cultivators and consumers. They provide advanced agricultural science services to plant growers.
Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 89
- Round size: Seed $750k–$6M; Series A $1.9M–$20M; Series B $5M–$30M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely still investing — raised $64M in 2022
Portfolio highlights
- Tombot — We create robotic animals that transform the daily lives of individuals, families, and communities facing health adversities. Reserve your Tombot Puppy today for FREE
- Materna Medical — Materna Medical empowers women to protect and restore their pelvic health.
- ChemT Biotechnology — The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 267
- Round size: Seed $300k–$6M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- LegiTime Technologies — LegiTime Technologies, Inc. provides LegiText, a subscription-based SMS solution that offers message authentication, categorization, and archiving based on demonstration of legitimacy technology. It also provides LegiTrac that locates and tracks devices, as well as back up and stores data in a central location; and LegiAlert that offers messagebroadcasts and alerts, creates groups and contact lists, and integrates contact information with existing back office data systems. The company serves enterprises and educational institutions, as well as consumer, finance and banking, and healthcare industries. LegiTime Technologies, Inc. was founded in 2005 and is based in Farmington, Connecticut.
MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 90
- Round size: Seed $50k–$700k; Series B $1.3M–$18M; Series C $5M–$28M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $22M in 2011
Portfolio highlights
- Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
- SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
- Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
TCA Venture Group is the largest angel investor group in the United States, possessing more than 300 members in five networks in Los Angeles, Orange County, San Diego, Central Coast, and the Inland Empire. Its members provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.Members invest in companies in a wide range of industries, including the life sciences, biotech, IT, services, retail, Internet, financial, software, media, consumer products, and tech startups. TCA as a whole gives companies more than just capital; they also provide counsel, mentoring, and access to an extensive network of potential investors, customers, strategic partners, and management talent. Tech Coast Angels has been ranked by CB Insights to be among the Top 20 Angel Groups in the US; TCA was also ranked as #1 for Network Centrality, meaning we have more connections than anyone! If you are in the game-changing business, we are here to help.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Convertible Note
- Geography: United States, Canada
Investor stats
- Total investments: 250
- Round size: Seed $600k–$4M; Convertible Note $100k–$7M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Curb — Power your home, smarter. Curb specializes in the fields of energy engagement software and home energy management. Curb makes it possible to take control of your home's electricity use with a single product, find out what appliances and devices are driving your energy bills up. It was founded in 2012 and headquartered in Austin, Texas.
- Terecircuits — Terecircuits develops processes and materials to support microassembly and mass transfer for displays and advanced electronics.
- MatriSys Bioscience — MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Maine Angels they make investments with entrepreneurs with an emphasis on businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States
Investor stats
- Total investments: 129
- Round size: Seed $25k–$1.2M; Series A $662k–$5.9M
- Lead/follow: 1% lead, 99% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Waku — Deliciously replenishing herbal tea with prebiotic powers and 0g of added sugar. Experience Sunrise on the Inside.
- HighByte — Architect your digital transformation and AI use cases with proven Industrial DataOps software from HighByte. Let's make your industrial data useful.
- Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
Providing Flexible and Creative Financial Solutions to Middle Market Companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Debt Financing, Post-IPO Debt, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 125
- Round size: Series B $39M–$76M; Post-IPO Debt $15M–$150M; Debt Financing $7.5M–$96M
- Lead/follow: 51% lead, 49% follow
Portfolio highlights
- Sokin — Sokin is a leading financial service provider that enables global payments for both consumers and businesses. Sokin believes in giving you the power to make payments and transfer money as many times as you want per month! Whether it’s sending money back home or transfers to friends or even settling with businesses using Sokin, our innovativeprocess makes the task quick and easy.Sokin delivers global payments for a fixed fee, is commission and hassle free!Transferring money internationally is complicated and expensive. Sometimes there is a lack of transparency in the fees you pay. With our transparent fixed monthly costs, for businesses and consumers, there are no hidden charges. You will not have to spend hours researching the best rates!Our cost effective solution is simple to understand: One Monthly Fee. This will to allow you to make payments in over 200 countries and the ability to exchange money in over 150 countries in over 35 different currencies. Sokin can also transfer any currency into any bank account in China within 2 hours excluding weekends and Chinese bank holidays.To find out more about the only payment provider to provide global payments for a fixed fee, commission free and hassle free – download our app and sign up to ensure you don’t miss out on key messages!
- Inhibrx — Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The Inhibrx pipeline is focused on oncology,orphan diseases, and infectious diseases. Inhibrx has collaborations with Celgene and Bluebird Bio and has received awards from several granting agencies, including NIH, NIAID, and CARB-X.
- Vortexa — State of the art energy analytics that paints a global picture of cargo flows. Identify energy market opportunities before the competition with Vortexa.
Keiretsu Capital LLC is an affiliate of the World's Leading Angel Network, Keiretsu Forum, and manages funds which enable limited partners to co-invest in the proprietary deal flow of the angel investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 169
- Round size: Seed $700k–$2.5M; Series A $1.2M–$12M
- Lead/follow: 2% lead, 98% follow
- Last fund: Likely still investing — raised $3.7M in 2022
Portfolio highlights
- MiClient — Miclient are deal closure platform which was founded by experienced sales leaders who recognized the need for a new generation of complicated quote configuration, contract signing, renewal & payment collection at one place for SMEs, Lead Management System, B2B SaaS, CRM software, CPQ (Configure- Price- Quote)
- Healionics — Healionics aims to provide safer, more reliable means of bloodstream access for dialysis in patients with kidney failure.
- NuvOx Therapeutics — NuvOx Pharma is a clinical stage biotech company developing an innovative platform of oxygen therapeutics to treat life-threatening diseases where hypoxia plays a role.
Upstate New York's most active nonprofit seed fund. Free mentoring, seed capital, and hands-on support for high-growth startups. 1,900+ companies mentored, 110+ funded, 9,900+ jobs created.
Show more...Investment focus
- Industry: Software, Health Care, Food and Beverage
- Stage:Convertible Note, Seed, Pre-Seed
- Geography: United States, Canada, Denmark
Investor stats
- Total investments: 190
- Round size: Seed $50k–$2.2M; Pre-Seed $81k–$1.3M; Convertible Note $13k–$585k
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Ognomy Sleep — Are you looking for a sleep apnea app? Ognomy brings the high-quality care you can expect from an online sleep doctor. Our mission is to improve global health by democratizing access to care for those who suffer from sleep apnea - over 1 billion people worldwide.
- Bridge Green Upcycle — Bridge Green Upcycle is a clean energy company that specializes in lithium-ion battery upcycling technology solutions.
- Casana — Casana is unlocking a new category in healthcare technologies that enable effortless, integrated and consistent in-home heart health monitoring. Casana’s first product, The Heart Seat™ is an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output.Casana’s mission is to assist medical teams in their care management of patients with chronic conditions beyond the four walls of the hospital, starting with the 6M+ people in the US living with Heart Failure.
Golden Seeds is a seed-stage investment firm with a focus on women leaders. Their investment thesis rests on the extensive research that concludes that gender-diverse teams produce a better return on equity. By seeking companies where women hold leadership positions and own substantial equity, they are funding companies that are likely to havediverse perspectives that will contribute to success.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 153
- Round size: Seed $740k–$5.6M; Series A $1.2M–$10M; Series B $1.8M–$20M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- RenovoRx — RenovoRx is a developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. RenovoRx received FDA clearance for the RenovoCath™ RC120 and is currently introducing this innovative technology to the clinical market.RenovoRx has a motivatedManagement Team with broad experience and an exciting vision for the future of targeted delivery. The company also has a broad Advisory Board of interventional radiologists, surgical oncologists and gastroenterologists that guide the company's clinical development strategies. RenovoRx is backed by a strong Board of Directors committed to long-term, continuous support of the company, whose members provide critical expertise in the medical and biotechnology industry and the visionary thinking to succeed.
- ColorModules — ColorModules is an early stage start-up which has created a patent-pending search technology that recommends products to consumers based on "visual" characteristics and preferences, such as color. ColorModules sets out to alleviate the common shopping frustration of searching dozens or hundreds of items to find the right product.Currently, ColorModules focuses on the visually-driven beauty, fashion, and home décor industries.Its first website, PlumPerfect.com, is for beauty shoppers. Users can take and upload a photo, and the service recommends for them colors and products.
- Style for Hire — Style for Hire is a national network of trained and certified personal stylists who bring affordable in-home wardrobe advice and shopping assistance to customers. Celebrity stylist Stacy London, from TLC's What Not to Wear, is co-founder, spokesperson, and Stylist-in-Chief.
Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Debt Financing, Post-IPO Debt, Series C
- Geography: United States, Canada, India
Investor stats
- Total investments: 109
- Round size: Series C $2.8M–$200M; Post-IPO Debt $10M–$40M; Debt Financing $5M–$30M
- Lead/follow: 71% lead, 29% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
- Stellar Cyber — Stellar Cyber: Automation-Driven, Open & Unified SecOps Platform with AI SIEM, NDR, Open XDR, and Multi-Layer AI.
- Hyperfine — Hyperfine makes MRI accessible to every patient regardless of income or resources.
Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Angel, Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 107
- Round size: Seed $100k–$2.9M; Angel $500k–$1.6M; Series A $662k–$6M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Gelmedix — Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients.
- Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
- Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United States, Israel, The Netherlands
Investor stats
- Total investments: 89
- Round size: Seed $1M–$4M; Series A $1.3M–$20M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ATDev — ATDev builds robotic mobility and assistive technology for elderly and disabled people, from the RAMMP mobility platform to the Reflex rehab knee brace.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
- Trio Pharmaceuticals — Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Good Growth Capital is an early-stage venture capital firm known for its expertise in finding, assessing and cultivating complex science and technology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Convertible Note
- Geography: United States, France, Israel
Investor stats
- Total investments: 118
- Round size: Seed $505k–$9M; Series A $4.2M–$20M; Convertible Note $25k–$300k
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $100M in 2023
Portfolio highlights
- Obsidio — Obsidio™ Conformable Embolic with aqueous gel technology is a 510(k) cleared device, the first of its kind to have a specific on-label indication for peripheral use in the U.S.
- Skyhawk Therapeutics — Skyhawk Therapeutics is a clinical-stage biotechnology company focused on the discovery and development of novel small molecule therapies designed to modulate critical RNA targets and revolutionize patient treatment for some of the world's most intractable diseases.
- Osteoboost — Bone Health Technologies specializes in developing medical devices designed for low bone mass. Its solution is a gentle mechanical stimulation that mimics weight-bearing exercise, providing an effective non-drug intervention. It offers the OsteoBoost device that relies on safe, natural, and effective whole-body vibration technology usingvibrational energy to turn stem cells into the bone using the same mechanisms as physical exercise. The company was founded in 2018 and is headquartered in San Francisco, California.
We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Grant, Debt Financing
- Geography: United States
Investor stats
- Total investments: 141
- Round size: Seed $100k–$2.2M; Grant $5k–$100k; Debt Financing $975k–$975k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
- Aigensei — Aigensei.ai develops artificial intelligence software and infrastructure tools that support the creation, deployment, and management of AI applications. Its work includes systems for workflow automation, model integration, and operational use of AI across different computing environments and application domains.
- LoanStar Technologies — LoanStar works with lenders to diversify their consumer loan origination strategies. Providing program consulting, market-leading software, and merchant aggregation, LoanStar helps lenders of every size leverage the power of their local brand.LoanStar has developed the MerchantLinQ platform that enables lenders of all sizes to deploy instantpoint-of-sale finance through their local merchants.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 296
- Round size: Series A $5M–$72M; Series B $10M–$107M; Series C $12M–$108M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Graphite Bio — Graphite Bio is a next-generation gene editing company focused on therapies that harness targeted gene integration to treat or cure serious diseases
- Dayra Therapeutics — Dayra Therapeutics manufactures peptide based medicines.
- Jecure Therapeutics — Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
Catalyst Health Ventures (CHV) is a Boston-based medtech VC firm backing early-stage healthcare technology founders since 2008.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: United States
Investor stats
- Total investments: 48
- Round size: Series A $1.4M–$19M; Series B $2.3M–$33M; Series C $1.3M–$85M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $75M in 2019
Portfolio highlights
- Lena Health — Lena is a virtual health assistant that takes care of all tasks to stay on top of the care plan, so you can sit back and focus on the things that matter to you.
- Epitel — Epilog is an unobtrusive wearable seizure detection system that records long-term EEG, anywhere. It gives people living with epilepsy peace of mind with a much-needed tool to better understand and manage their seizures.
- Rejoni — Rejoni uses bio-materials to develop medical devices that improve the outcome of minimally invasive and gynecological surgical procedures.
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 134
- Round size: Series A $8.2M–$50M; Series B $5M–$90M; Series C $8M–$88M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Ribometrix — The Next Frontier of Drug Discovery
- G1 Therapeutics — G1 Therapeutics is a clinical-stage company developing novel cancer therapies. It was founded in 2008 by Drs. Norman Sharpless and Kwok-Kin Wong to capitalize on discoveries made and patented by Dr. Sharpless’ lab at the University of North Carolina at Chapel Hill, and subsequently licensed to G1 Therapeutics. Trilaciclib is an investigationaltherapy designed to improve outcomes for people with cancer who are treated with chemotherapy. G1 is also advancing rintodestrant, a potential best-in-class oral selective estrogen receptor degrader, or SERD, for the treatment of ER+ breast cancer.
- Viamet Pharmaceuticals — Viamet Pharmaceuticals discovers and develops "best-in-class" inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, their Metallophileâ„¢ Technology. Viamet's disruptive Metallophileâ„¢ technology is based on their world-class expertise in bioinorganic chemistry and metalloenzymes and allowsthem to identify validated targets with high therapeutic and commercial potential; leverage existing metalloenzyme inhibitors as the basis for Viamet's best-in-class analogs; and rapidly and cost-effectively generate best-in-class, patentable, small molecule compounds by optimizing the metal-binding component of existing inhibitors.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 1093
- Round size: Seed $1.2M–$6.5M; Pre-Seed $500k–$2.6M; Series A $8M–$20M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Suma Wealth — Meet Charlie, your AI financial coach inside the SUMA app. Get personalized budgeting, savings, and investing advice in English or Spanish.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members. Membership has grown to 50+ members in recent years, bringing significant knowledge and experience.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 115
- Round size: Seed $400k–$3M; Series A $1.1M–$7M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- DropCap — International Rights Platform for Books | DropCap
- Cylerity — Transform healthcare receivables into real-time capital. Cylerity unlocks cash flow, clarity, and control from claims data. See how it works.
- Midwest Games — Midwest Games is a video game publisher focused on creating opportunities for the abundant talent across the Midwest and other underrepresented regions.
Boutique Venture Partners specializes in early-stage investments in healthcare and life sciences
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 37
- Round size: Seed $2.5M–$5.7M; Pre-Seed $1.8M–$2.6M; Series A $4M–$31M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- QMENTA — Our industry-leading neuroimaging cloud-based software works with advanced AI-powered tools to empower researchers, radiologists, and clinical trials.
- Handl Health — Making healthcare price transparency simple, insightful and actionable.
- Ventaris Surgical — Ventaris Surgical is a medical equipment company that provides surgical instruments to specialists.
SBXi is jointly sponsored by nine firms. We offer equity funding for MIT founders who are working on a term sheet with a lead investor.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: United States, India, Mexico
Investor stats
- Total investments: 186
- Round size: Seed $150k–$7M; Pre-Seed $100k–$1.5M; Venture - Series Unknown $3M–$6.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LineWise — LineWise, a Y Combinator-backed startup, helps manufacturers maximize production uptime. We use AI to diagnose machine failures, accelerate troubleshooting
- Spectrohm — Spectrohm is the next generation of internal imaging.
- Autonomous Cyber — Autonomous Cyber is an artificial intelligence platform for cybersecurity solutions.
Rev1 Ventures is a venture studio in Columbus, Ohio providing tech startups with services, space, mentoring, and connections. Learn more!
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: United States, Germany
Investor stats
- Total investments: 200
- Round size: Seed $192k–$4M; Series A $1.2M–$18M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $20M in 2021
Portfolio highlights
- FinOpsly — Maximize your cloud ROI with FinOpsly. Our AI-driven platform empowers organizations with smart cost management, fostering collaboration across teams for over 32% in savings. Simplify your cloud strategy with FinOpsly.
- InnerActiv — InnerActiv is the leading NextGen eDLP solution, setting new standards in DLP, fraud and insider threat detection.
- Niobium Microsystems — The encrypted cloud has arrived.
Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 116
- Round size: Seed $100k–$6M; Series A $3.5M–$40M; Series B $8M–$100M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- SyntaxBio — SyntaxBio develops CRISPR/Cas9-based, genetic programming platform that converts cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform can program cells without the need for consistent external intervention.
- ElectroKare — Train like the 1%. Electrokare turns wearables into a real-time coaching layer, with electrolyte tracking, ECG integration, and AI-driven performance insights built for elite training.
- Transcripta Bio — Drug discovery at the resolution of biology. Using the power of the transcriptome to discover revolutionary medicines.
U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series C, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 426
- Round size: Series A $5M–$42M; Series B $7M–$51M; Series C $7.8M–$68M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Nervonik — Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.
- Cagent Vascular — Cagent Vascular pioneers Serration Remodeling Therapy (SRT) creating controlled lines of weakness to release the internal elastic lamina, reducing recoil and increasing luminal gain in PAD angioplasty.
- Maneva — Maneva Copilot AI is able to interpret, summarize, and combine the diverse landscape of data that exists throughout your production facility, and deliver the appropriate content to the question provided at all levels of roles, whether it is operational supervisors, quality managers, and management, process engineers, or maintenance leads
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Keiretsu Forum is a global angel investor network with more than 2,500 accredited investor members throughout 47 chapters on 3 continents.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United States, India, Turkey
Investor stats
- Total investments: 241
- Round size: Seed $85k–$3.3M; Series A $778k–$10M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $10M in 2015
Portfolio highlights
- Bliss — Skip long waitlists and expensive therapy. Book licensed online therapists in multiple languages with culturally informed care.
- BatteryPool — BatteryPool offers battery charging solutions for EV fleets and commercial vehicles.
- Apriority Financial — Apriority Financial is a debt optimization platform that manages and optimizes employee personal debt.
The St. Louis Arch Angels is a network of accredited investors who fund early-stage businesses across the St. Louis region.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: United States, Argentina
Investor stats
- Total investments: 76
- Round size: Seed $100k–$3.3M; Series A $1.5M–$8.5M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Peptyde Bio — Peptyde Bio is an Agtech startup positioned to become the go-to supplier of new AMPs.
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Maximum Fidelity Surgical Simulations — The most realistic surgical and trauma simulations for surgeons, forward field operators, medics and medical device development.
Kleiner Perkins is a venture capital firm specializing in investing in early-stage, growth, and incubation companies. The firm continues that legacy, investing in founders with bold ideas that span industries and continents, partnering with them from inception to IPO and beyond to maximize the potential of their ideas. They also focus on earlycomputer firms using their devices and programming and service companies. It also invests in the digital, life sciences, and healthcare industries.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 1031
- Lead/follow: no public data
Portfolio highlights
- Synthesia — Create AI videos by simply typing in text. Make engaging videos for e-learning, customer onboarding, etc. No need for actors, cameras or audio equipment.
- Biz AI Last — Are you ready to elevate your business efficiency and productivity? Say hello to Biz AI, your intelligent business assistant designed to streamline operations, boost productivity, and give you more time to focus on what matters most – growing your business.
- Hippocratic AI — The First Safety Focused LLM for Healthcare
ShangBay Capital is a venture capital company that brings best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early-stage venture equity participation
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, China, Canada
Investor stats
- Total investments: 50
- Round size: Series A $5.1M–$25M; Series B $10M–$123M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $48M in 2021
Portfolio highlights
- Nervonik — Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.
- Sound Health — Sound Health uses acoustic resonance to provide nasal relief. Its current product is an app that scans the face to map the bone structure and then a headband that plays music at personalized frequencies for 10 minutes. The headband is off the shelf and the sound levels are akin to wearing earpods. It envisions the headband to be over-the-counter(OTC) so it’s easily accessible to patients, whether prescribed by doctors or not.
- Sound Health & Wellness Center — The Sound Health & Wellness Trust is a Taft-Hartley trust managed jointly by unions and employers and providing benefits to more than 51,000 participants.
The Houston Angel Network (HAN) is a nonprofit organization dedicated to developing the innovation ecosystem in Houston, Texas by supporting founders and startups with financial resources and mentorship.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, France
Investor stats
- Total investments: 133
- Round size: Seed $25k–$1.8M; Series A $240k–$5M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- ITeam — iTeam is transforming the way information technology (IT) and audio/video (A/V) installation services are packaged, sold and delivered through a new approach called Service-as-a-Product™ (SaaP™).
- Fusion Mobile — Fusion Mobile is a prepaid wireless company focused on the Hispanic population in the Southwestern U.S.
- Organ Transport Systems — Time-critical organ transport needs one operating view.
Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Sweden
Investor stats
- Total investments: 94
- Round size: Seed $420k–$3.2M; Series A $1.3M–$18M; Series B $2.1M–$45M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Vellum Health — Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients.
- Affineon Health — Affineon is the AI inbox that saves provider time. We automatically handle normal and clinically insignificant lab results, and help providers get through abnormal lab results faster. Our AI automatically groups, analyzes, and trends lab results into a smart summary, including possible next steps and a complete patient note. We also route"noise" to staff, reducing the number of messages a physician needs to pay attention to by up to 30%. The result is 5+ hours saved per week per provider. Plus, Affineon tightly integrates with the EHR, so providers don’t need to change their existing workflow.
- Mobia Medical — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firmsprogress in life-changing medicines, technologies, and diagnostics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States
Investor stats
- Total investments: 173
- Round size: Series A $19M–$110M; Series B $11M–$190M; Series C $20M–$108M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- NinePoint Medical — NinePoint Medical, Inc. is a transformational medical device company developing innovative, real-time, in vivo pathology devices. The company's first goal is to develop a device that enables remote pathology, or telepathology, which would facilitate immediate review of images during diagnostic procedures. This capability could potentiallyprovide physicians with immediately actionable information and eventually allow them to pursue therapeutic remedies at the time of diagnosis. This convergence of access, diagnosis and treatment during one procedure is expected to improve patient experiences and outcomes, improve the efficiency of care and provide important savings to the healthcare system. Headquartered in Cambridge, Mass., NinePoint is backed by Third Rock Ventures and Prospect Venture Partners.
- CytomX Therapeutics — CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
AMV is the leading early-stage venture capital firm investing in digital health, technology and life sciences. It has assembled the leading early-stage
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: United States, Cyprus, Ireland
Investor stats
- Total investments: 145
- Round size: Seed $500k–$6M; Series A $2.4M–$21M; Series B $5M–$35M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $150M in 2020
Portfolio highlights
- SeeQC — SEEQC is developing the first digital quantum computing platform for businesses. SEEQC combines classical & quantum technologies to address the efficiency, stability & cost issues endemic to quantum computing.
- Outcomes4Me — Outcomes4Me is empowering cancer patients globally with treatment options, medical records, and clinical trials all in one app.
- Autonomize AI — Transform healthcare with our innovative Healthcare AI platform that enhances workflows and boosts efficiency.
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 161
- Round size: Seed $210k–$4.3M; Series A $100k–$11M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
- Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
- Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 70
- Round size: Series B $5M–$60M; Series C $1.5M–$77M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — raised $10M in 2006
Portfolio highlights
- Luminopia — Luminopia is the first FDA-approved binocular therapy for amblyopia.
- Mobia Medical — MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases. Its therapies include paired vagus nerve stimulation system (Paired VNS System) and wireless neurostimulation system for the treatment of chronic pain, post-stroke upper limb mobility issues, and variousneurological indications that enable healthcare practitioners to treat post-stroke upper limb mobility issues.Founded in 2007, MicroTransponder is headquartered in Dallas, Texas.
- Route 92 Medical — The official website for Route 92 Medical.
Medical Device Investor funding in United States at a glance
Stats across 7k deals from 5.2k investors.
Access all 5158 investors in United States Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in United States investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 5158 investors investing in United States Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!